| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/24/2007 | WO2007057691A2 Therapeutic uses of steroidal compounds |
| 05/24/2007 | WO2007057688A1 Method for adminstering carotenoids to salmonids |
| 05/24/2007 | WO2007057687A1 Piperazine derivatives and their use in therapy |
| 05/24/2007 | WO2007057670A1 Nidogen/snep-iike molecule |
| 05/24/2007 | WO2007057598A2 Pharmaceutical or cosmetic composition and a mixed solubilisation method for the production thereof |
| 05/24/2007 | WO2007057583A1 Cosmetic and pharmaceutical compositions comprising lauroyl proline and an ester of anhydrohexitol and of an aliphatic carboxylic acid |
| 05/24/2007 | WO2007057571A2 3-acylindole derivatives the preparation and the therapeutic use thereof |
| 05/24/2007 | WO2007057466A1 Rapamycin derivative or an impdh inhibitor for treating polycystic kidney disease |
| 05/24/2007 | WO2007057457A2 Neuroendocrine tumor treatment using mtor inhibitors |
| 05/24/2007 | WO2007057447A1 Novel quinazoline derivatives and their medical use |
| 05/24/2007 | WO2007057440A2 Improved methods of using phosphoantigen for the treatment of cancer |
| 05/24/2007 | WO2007057431A1 New method for treating cancer based on the modulation of calcineurin |
| 05/24/2007 | WO2007057399A2 Treatment of cancer with indole derivatives |
| 05/24/2007 | WO2007057397A1 Treatment of cancer |
| 05/24/2007 | WO2007057329A1 Azaindole-2-carboxamide derivatives |
| 05/24/2007 | WO2007057317A1 Novel pyrrolidine derivatives as inhibitors of coagulation factor xa |
| 05/24/2007 | WO2007057232A1 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments |
| 05/24/2007 | WO2007057229A1 4-oxadiazolyl-piperidine compounds and use thereof |
| 05/24/2007 | WO2007057223A1 Organic compounds comprising a glycopyrronium salt |
| 05/24/2007 | WO2007057222A1 Organic compounds comprising a glycopyrrolium salt |
| 05/24/2007 | WO2007057221A2 Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases |
| 05/24/2007 | WO2007057219A1 Treatment of asthma and copd using triple-combination therapy |
| 05/24/2007 | WO2007057181A1 Use of aza-phenylalanine compounds for treating cardiac arrhythmia |
| 05/24/2007 | WO2007057152A1 17.beta.-fluoromethoxycarbonyl-androst-4-en-3-one compounds with a 17.alpha.-carbonate substituent |
| 05/24/2007 | WO2007057128A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
| 05/24/2007 | WO2007057093A1 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazine derivatives |
| 05/24/2007 | WO2007057092A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines |
| 05/24/2007 | WO2007057091A1 Flavone sulfates and their use as antioxidants |
| 05/24/2007 | WO2007057090A1 A combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer |
| 05/24/2007 | WO2007056955A1 Pyrazolopyrimidinone derivatives, their preparation and their use |
| 05/24/2007 | WO2007056941A1 The use of isothiocyanates compounds in treating prostatic diseases and skin cancer |
| 05/24/2007 | WO2007056870A1 Methods and compositions for pharmacologically controlled targeted immunotherapy |
| 05/24/2007 | WO2007056861A1 Sirna silencing of influenza virus gene expression |
| 05/24/2007 | WO2007056851A1 Compositions and methods for enhancing ovulation inducing agents |
| 05/24/2007 | WO2007056846A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/24/2007 | WO2007056829A1 Multitargeting interfering rnas having two active strands and methods for their design and use |
| 05/24/2007 | WO2007056826A1 Multitargeting interfering rnas and methods of their use and design |
| 05/24/2007 | WO2007056817A1 Pharmacologically active compounds containing sulfur |
| 05/24/2007 | WO2007056813A1 Pediculicide/ovicide composition |
| 05/24/2007 | WO2007047921A3 Dual-phase cement precursor systems for bone repair |
| 05/24/2007 | WO2007044449A3 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 05/24/2007 | WO2007041206A3 Drug delivery nanocarriers targeted by landscape phage |
| 05/24/2007 | WO2007040650A3 Apoptosis promoters |
| 05/24/2007 | WO2007040591A9 A ubiquinone composition and a container for its convenient transport and storage |
| 05/24/2007 | WO2007038524A3 Cocrystallization methods |
| 05/24/2007 | WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound |
| 05/24/2007 | WO2007036671A3 Microparticles with modified release of at least one active principle and oral galenic form comprising same |
| 05/24/2007 | WO2007034042A3 Vanilla planifolia extract, method for obtaining same, and cosmetic or dermatological composition containing same |
| 05/24/2007 | WO2007032005A3 Novel amine-borane compounds and uses thereof |
| 05/24/2007 | WO2007031557A3 Alcanoic acid amides substituted by saturated o-heterocycles |
| 05/24/2007 | WO2007030166A3 TRICYCLIC 6-ALKYLIDENE-PENEMS AS CLASS-D β-LACTAMASES INHIBITORS |
| 05/24/2007 | WO2007028163A8 Biocompatible fluorescent imaging agents |
| 05/24/2007 | WO2007028101A9 Osteogenic and anti-adiogenic oxysterols |
| 05/24/2007 | WO2007027527A3 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 05/24/2007 | WO2007025213A3 Use of sodium channel blockers for the management of musculoskeletal pain |
| 05/24/2007 | WO2007024860A3 Sulfonamides |
| 05/24/2007 | WO2007024600A3 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof |
| 05/24/2007 | WO2007022044A3 Combination of organic compounds |
| 05/24/2007 | WO2007022030A3 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals |
| 05/24/2007 | WO2007020671A8 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 05/24/2007 | WO2007020479A3 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 05/24/2007 | WO2007020195A3 Peg-ifn alpha and ribavirin for hbv treatment |
| 05/24/2007 | WO2007018738A8 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 05/24/2007 | WO2007017914A3 Dermonecrotizing protein factors of bacterial origin and related uses in medical field |
| 05/24/2007 | WO2007017291A3 Production of an oxaliplatin mixture and a container and a container set for said mixture |
| 05/24/2007 | WO2007017191A3 Compositions comprising an no donor and a dithiolane and their use for improvement of sexual function |
| 05/24/2007 | WO2007016392A3 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| 05/24/2007 | WO2007016352A3 Oral liquid losartan compositions |
| 05/24/2007 | WO2007009147A3 Homogemcitabines |
| 05/24/2007 | WO2007008463A3 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 05/24/2007 | WO2007006566A8 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
| 05/24/2007 | WO2007006533A3 Indolylmaleimide derivatives |
| 05/24/2007 | WO2007002587A3 Inhibitors of epstein barr virus nuclear antigen 1 |
| 05/24/2007 | WO2007002516A3 Improved dosage forms for movement disorder treatment |
| 05/24/2007 | WO2007001455A3 Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants |
| 05/24/2007 | WO2006138304A3 Pyrimidine compounds |
| 05/24/2007 | WO2006135933A3 Stable fixed-dose unitary formulations containing tenofovir, a surfactant, efavirenz and emtricitabine |
| 05/24/2007 | WO2006135932A3 Stable fixed-dose formulations containing a combination of antivirals, method for producing thereof using dry granulation |
| 05/24/2007 | WO2006135431A3 Inhibition of metallo-beta-lactamase by rna |
| 05/24/2007 | WO2006128173A3 Selective apoptotic induction in cancer cells including activation of procaspase-3 |
| 05/24/2007 | WO2006120705B1 Treatment and control of severe infections including cystic fibrosis |
| 05/24/2007 | WO2006119758B1 Dihydroxyphenylalanine derivatives |
| 05/24/2007 | WO2006118954A3 Inhibition of reactive oxygen species and protection of mammalian cells |
| 05/24/2007 | WO2006114277A3 Dosage form with improved release of cefuroximaxetil |
| 05/24/2007 | WO2006102611A3 Therapeutic agents for the treatment of leukemia |
| 05/24/2007 | WO2006101538A3 Andrographolide derivatives to treat viral infections |
| 05/24/2007 | WO2006098998A3 Methods and compositions for modulating vascular integrity |
| 05/24/2007 | WO2006091522A3 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| 05/24/2007 | WO2006071960A3 Compositions and methods of treating cell proliferation disorders |
| 05/24/2007 | WO2006055632A3 Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions |
| 05/24/2007 | WO2006042150A8 Diaminoalkane aspartic protease inhibitors |
| 05/24/2007 | WO2006039582A3 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells |
| 05/24/2007 | WO2006035431A3 Fatty acid modified polylysines as antimicrobial agents |
| 05/24/2007 | WO2006029221B1 Anti-tumor compounds with angeloyl groups |
| 05/24/2007 | WO2006021655A8 Oxopiperidine derivatives, preparation and therapeutic use thereof |
| 05/24/2007 | WO2006021654A8 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof |
| 05/24/2007 | WO2005115381A3 COMPOSITION CONTAINING POLICOSANOL AND HMG-Co-A REDUCTASE INHIBITOR AND THEIR PHARMACEUTICAL USES |
| 05/24/2007 | WO2005091739A3 Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals |
| 05/24/2007 | WO2005082008A3 Methods for diagnosing and treating bladder cancer |
| 05/24/2007 | WO2005046610A3 Genes differentially expressed by acutely isolated resident progenitor cells of the human white matter |